These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4608821)

  • 1. Diodoquin (diiodohydroxyquin) toxicity (blindness) in children.
    Drake ME; Drake ME
    J Med Soc N J; 1974 Oct; 71(10):792-3. PubMed ID: 4608821
    [No Abstract]   [Full Text] [Related]  

  • 2. Blindness during diiodohydroxyquin (Diodoquin) therapy: a case report.
    Fleisher DI; Hepler RS; Landau JW
    Pediatrics; 1974 Jul; 54(1):106-8. PubMed ID: 4600583
    [No Abstract]   [Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Drugs: Clioquinol (iodochlorhydroxyquin, vioform) and iodoquinol (diiodohydroxyquin): blindness and neuropathy.
    Pediatrics; 1990 Nov; 86(5):797-8. PubMed ID: 2146587
    [No Abstract]   [Full Text] [Related]  

  • 4. Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on drugs.
    Pediatrics; 1974 Sep; 54(3):378-9. PubMed ID: 4278011
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Diiodohydroxyquin and optic atrophy.
    Idriss ZH
    Pediatrics; 1975 Feb; 55(2):299. PubMed ID: 1090898
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Acrodermatitis enteropathica.
    Klein A
    Arch Dermatol; 1974 Nov; 110(5):819-20. PubMed ID: 4607921
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Diiodohydroxyquin warning.
    Blakey D
    J Miss State Med Assoc; 1975 Feb; 16(2):46. PubMed ID: 122845
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Optic atrophy in children after diiodohydroxyquin therapy.
    Behrens MM
    JAMA; 1974 May; 228(6):693-4. PubMed ID: 4595101
    [No Abstract]   [Full Text] [Related]  

  • 9. DIODOQUIN IN TREATMENT OF HISTOPLASMOSIS UVEITIS.
    LEBENSOHN JE
    Am J Ophthalmol; 1964 Jan; 57():145-6. PubMed ID: 14106897
    [No Abstract]   [Full Text] [Related]  

  • 10. Optic atrophy following treatment with diiodohydroxyquin.
    Pittman FE; Westphal MC
    Pediatrics; 1974 Jul; 54(1):81-3. PubMed ID: 4599475
    [No Abstract]   [Full Text] [Related]  

  • 11. Iodoquinol associated seizures and radiopacity.
    Fisher AK; Walter FG; Szabo S
    J Toxicol Clin Toxicol; 1993; 31(1):113-20. PubMed ID: 8433407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diodoquin as a topical therapeutic agent in cutaneous disease.
    LEIFER W; STEINER K
    J Invest Dermatol; 1949 Apr; 12(4):203. PubMed ID: 18120698
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems with di-iodohydroxyquin.
    Price RB
    N Engl J Med; 1972 Nov; 287(20):1048. PubMed ID: 4568397
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of diiodohydroxyquin by non-aqueous titration.
    KAVARANA HH
    Am J Pharm Sci Support Public Health; 1959 May; 131(5):184-7. PubMed ID: 13661323
    [No Abstract]   [Full Text] [Related]  

  • 15. Diodoquin in the treatment of chronic diarrhea.
    JENKS AL
    J Iowa State Med Soc; 1957 Aug; 47(8):529-31. PubMed ID: 13449379
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative studies on the iodine absorption of anayodin, chiniofon, diodoquin, and vioform in man.
    KNIGHT AA; MILLER J
    Ann Intern Med; 1949 Jun; 30(6):1180-7. PubMed ID: 18150179
    [No Abstract]   [Full Text] [Related]  

  • 17. Enteropathic acrodermatitis (Danbolt-Closs) and diodoquin treatment.
    SUNDAL A
    Ann Paediatr Fenn; 1957; 3(3):486-93. PubMed ID: 13470572
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative studies on the iodine absorption of anyodin, chiniofon, diodoquin, and vioform in man.
    KNIGHT AA; MILLER J
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():75. PubMed ID: 20272837
    [No Abstract]   [Full Text] [Related]  

  • 19. Diodoquin therapy of zinc deficiency in rats.
    Bettger WJ; O'Dell BL
    Am J Clin Nutr; 1980 Oct; 33(10):2223-4. PubMed ID: 6775522
    [No Abstract]   [Full Text] [Related]  

  • 20. Acrodermatitis enteropathica with secondary lactose intolerance, and tertiary deficiency state, probably due to chelation of essential nutrients by di-iodohydroxyquinolone.
    Moynahan EJ
    Proc R Soc Med; 1966 May; 59(5):445-7. PubMed ID: 5326958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.